Non-coding genetic variants underlying higher prostate cancer risk in men of African ancestry
2024

Genetic Variants Linked to Prostate Cancer Risk in African Men

Sample size: 140306 publication 10 minutes Evidence: high

Author Information

Author(s): Hannenhalli Sridhar, Li Shan, Fatema Kaniz, Nidharshan Sundarraj, Singh Arashdeep, Rajagopal Padma Sheila, Notani Dimple, Takeda David

Primary Institution: National Institutes of Health

Hypothesis

The study aims to identify non-coding genetic variants that contribute to higher prostate cancer risk in men of African ancestry.

Conclusion

The study identified approximately 2,000 genetic variants that may influence prostate cancer risk in African American men through their effects on enhancer function.

Supporting Evidence

  • Men of African ancestry are at a higher risk of prostate cancer compared to those of European ancestry.
  • Identified SNPs may influence immune response and cell differentiation related to cancer.
  • Polygenic risk scores based on identified SNPs can better predict prostate cancer risk.

Takeaway

Scientists found specific genetic changes that might make African American men more likely to get prostate cancer, helping to understand why this happens.

Methodology

The study used a deep learning model to analyze non-coding SNPs and their effects on enhancer activity in prostate tissue.

Potential Biases

Potential bias may arise from the reliance on specific ancestral populations, which may not generalize to other groups.

Limitations

The study primarily focuses on genetic variants and may not account for environmental or lifestyle factors affecting prostate cancer risk.

Participant Demographics

The study focuses on men of African ancestry, particularly African American men.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.21203/rs.3.rs-5485172

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication